seek and you will find
Home
Technology
Products
Products Overview
SeekInCare
SeekInCure
SeekInClarity
OncoSeek
LungCanSeek
OncoGate
LeukoPrint
OncoGraph
PanCanSeek
SeekInEZ
EGFRseek
PHLseek
SeekInJoy
PetCanSeek
Publication
Research
Others
Newsroom
Product & Service Inquiry
…
Home
Technology
Products
Products Overview
SeekInCare
SeekInCure
SeekInClarity
OncoSeek
LungCanSeek
OncoGate
LeukoPrint
OncoGraph
PanCanSeek
SeekInEZ
EGFRseek
PHLseek
SeekInJoy
PetCanSeek
Publication
Research
Others
Newsroom
Product & Service Inquiry
seek and you will find
Home
Technology
Products
Products Overview
SeekInCare
SeekInCure
SeekInClarity
OncoSeek
LungCanSeek
OncoGate
LeukoPrint
OncoGraph
PanCanSeek
SeekInEZ
EGFRseek
PHLseek
SeekInJoy
PetCanSeek
Publication
Research
Others
Newsroom
Product & Service Inquiry
…
Home
Technology
Products
Products Overview
SeekInCare
SeekInCure
SeekInClarity
OncoSeek
LungCanSeek
OncoGate
LeukoPrint
OncoGraph
PanCanSeek
SeekInEZ
EGFRseek
PHLseek
SeekInJoy
PetCanSeek
Publication
Research
Others
Newsroom
Product & Service Inquiry
All Categories - SeekIn
All
Early cancer detection
Treatment response recurrence monitoring
Blood cancer solutions
Personal health Insights
Multi-omics pan-cancer early detection
Pan-cancer, post-surgical recurrence monitoring
Suggested Use: Adults with an elevated risk of cancer
Pan-cancer, pan-indication treatment response monitoring
Suggested Use: Late-stage cancer patients
AI-powered multi-cancer early detection
Suggested Use: Adults with an elevated risk of cancer
Lung cancer early detection
AI-powered cancer risk assessment
Molecular karyotyping
Suggested Use: Patients with suspected or confirmed leukemia (MDS/AML/ALL/CLL/MM)
PTMs-based personalized tumor surveillance
Suggested Use: Postoperative cancer patients for recurrence monitoring and treatment response evaluation
WGS-based mutational profiling
Simplified pan-cancer early detection
EGFR-guided treatment and monitoring
BCR-ABL–guided treatment and monitoring
Whole-genome analysis for personal health
Cancer early detection for dogs
SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.
Explore SeekIn's products
Newsroom
SeekIn Showcases the Advances in Multi‑Cancer Early Detection, Risk Stratification...
April 16, 2026
·
Press Releases
SeekIn’s OncoSeek Multi-Cancer Early Detection Technology Receives ...
April 10, 2026
·
Press Releases
SeekIn Inc. launches OncoGate, an AI-powered cancer risk assessment ...
April 7, 2026
·
Press Releases
SeekIn Announces Launch of OncoSeek Multi‑Cancer Early Detection Test...
January 15, 2026
·
Press Releases
Seekln 2025 Annual Report:Milestones in Our Journey
December 29, 2025
·
Press Releases
SeekIn Inc. Announces Publication in Blood Advances Demonstrating That...
December 17, 2025
·
Press Releases
More Posts
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Accept
Learn More